EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Preclinical safety and efficacy of an allogeneic adipose-derived mesenchymal stem cell medicinal product for rotator cuff repair: a two-phase experimental study

Yaiza Lopiz, Virginia Ponz-Lueza, Camila Arvinius, Cruz Rodríguez-Bobada, Francisco Rojo-Pérez, Pilar Tornero-Esteban, Fernando Marco

Journal of Shoulder and Elbow Surgery · 2026-12 · 35 (12) · 2851-2863

DOI: 10.1016/j.jse.2026.06.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Shoulder and Elbow Surgery, 2026-12. Verfasst von Yaiza Lopiz und 6 weiteren Autor:innen. Beteiligte Einrichtung: Shoulder and Elbow Unit, Department of Orthopaedic Surgery and Traumatology, Clínico San Carlos Hospital, Madrid, Spain; Surgery Department, Faculty …. Hauptthemen laut MEDLINE: Mesenchymal Stem Cell Transplantation, Rotator Cuff Injuries, Adipose Tissue. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Carlos III Health Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Cell therapy with adipose-derived mesenchymal stem cells (ASCs) is a promising biological augmentation strategy for rotator cuff repair; however, before clinical translation, regulatory frameworks mandate rigorous preclinical characterization of safety. We report the complete preclinical program evaluating both the safety of an allogeneic ASC-based cell therapy medicinal product (CTMP) and its efficacy in a chronic rotator cuff tear model. METHODS: Phase I (safety, 164 immunodeficient nude BALB/c mice) assessed toxicity, biodistribution, and tumorigenicity after intra-articular and intravenous administration at doses ranging from 10× to 1,000× the projected clinical dose. Toxicity was evaluated by biochemical panels and full-body histopathology at 90 days. Biodistribution was quantified by fluorodeoxyglucose-positron emission tomography/computed tomography (days 45 and 90) and human-specific quantitative polymerase chain reaction (Alu-repeat) at 90 days. Tumorigenicity used an HT-29 positive-control model. Phase II (efficacy, 48 Sprague-Dawley rats) used a validated 4-week chronic supraspinatus tear-and-repair model; after repair, animals received ASCs in suspension (n = 24) or Hypothermosol vehicle (n = 24) and were assessed histologically (Åström-Rausing scale) and biomechanically (Instron 4,411) at 4 months. RESULTS: In Phase I, no biochemical or histopathological toxicity attributable to the CTMP was detected at any dose or route. Three animals showed fluorodeoxyglucose-PET findings compatible with neoplasm but were histologically negative, confirming assay specificity. Quantitative polymerase chain reaction detected strong human DNA signals exclusively at the highest intravenous doses (≥500×), limited to the injection site (tail) and one heart sample; maximum retention was 1.75% at 90 days. After intra-articular administration at the clinical dose (10×), human ASCs persisted locally in 21% of animals at 90 days with no systemic dissemination. In Phase II, no statistically significant differences between groups were found in total histological score (median: 2 vs. 1; P = .811), any individual histological parameter, maximum load to failure (51.99 ± 9.1 N vs. 50.97 ± 9.1 N; P = .770), tendon displacement (5.33 ± 1.2 mm vs. 5.53 ± 1.4 mm; P = .852), or stiffness (17.28 ± 4.96 N/mm vs. 14.85 ± 4.01 N/mm; P = .669). CONCLUSIONS: This allogeneic ASC-based CTMP demonstrated a favorable safety profile across all tested doses and administration routes, supporting its candidacy for clinical development. Efficacy in suspension delivery over a repaired chronic tear was not demonstrated; immune-mediated rejection and mechanical displacement represent additional explanatory factors alongside cell retention failure, and should guide the design of next-generation delivery strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mesenchymal Stem Cell TransplantationRotator Cuff InjuriesAdipose TissueAnimalsMiceRats, Sprague-DawleyRatsMice, NudeMice, Inbred BALB CDisease Models, AnimalHumansMale

Stichwörter der Autor:innen

Adipose-derived stem cellsBiodistributionCell therapy medicinal productChronic tearEnthesis healingPreclinical safetyRotator cuff

Autor:innen und Institutionen

  • Shoulder and Elbow Unit, Department of Orthopaedic Surgery and Traumatology, Clínico San Carlos Hospital, Madrid, Spain; Surgery Department, Faculty of Medicine, Universidad Complutense de Madrid, Madrid, Spain. Electro…
  • Shoulder and Elbow Unit, Department of Orthopaedic Surgery and Traumatology, Clínico San Carlos Hospital, Madrid, Spain.
  • Unit of Experimental Medicine and Surgery, Clínico San Carlos Hospital, Madrid, Spain.
  • Department of Materials Science, Universidad Politécnica de Madrid, Centre for Biomedical Technology, Madrid, Spain.
  • Institute for Health Research, Hospital Clínico San Carlos (IdISSC), Madrid, Spain.
  • Shoulder and Elbow Unit, Department of Orthopaedic Surgery and Traumatology, Clínico San Carlos Hospital, Madrid, Spain; Surgery Department, Faculty of Medicine, Universidad Complutense de Madrid, Madrid, Spain.

Förderung

  • Carlos III Health Institute

Zitieren

APA

Lopiz, Y., Ponz-Lueza, V., Arvinius, C., Rodríguez-Bobada, C., Rojo-Pérez, F., Tornero-Esteban, P., & Marco, F. (2026). Preclinical safety and efficacy of an allogeneic adipose-derived mesenchymal stem cell medicinal product for rotator cuff repair: a two-phase experimental study. Journal of Shoulder and Elbow Surgery, 35(12), 2851-2863. https://doi.org/10.1016/j.jse.2026.06.005

Vancouver

Lopiz Y, Ponz-Lueza V, Arvinius C, Rodríguez-Bobada C, Rojo-Pérez F, Tornero-Esteban P, et al. Preclinical safety and efficacy of an allogeneic adipose-derived mesenchymal stem cell medicinal product for rotator cuff repair: a two-phase experimental study. Journal of Shoulder and Elbow Surgery. 2026;35(12):2851-2863. doi:10.1016/j.jse.2026.06.005

BibTeX
@article{Lopiz2026,
  author = {Lopiz, Yaiza and Ponz-Lueza, Virginia and Arvinius, Camila and Rodríguez-Bobada, Cruz and Rojo-Pérez, Francisco and Tornero-Esteban, Pilar and Marco, Fernando},
  title = {Preclinical safety and efficacy of an allogeneic adipose-derived mesenchymal stem cell medicinal product for rotator cuff repair: a two-phase experimental study},
  journal = {Journal of Shoulder and Elbow Surgery},
  year = {2026},
  volume = {35},
  number = {12},
  pages = {2851--2863},
  doi = {10.1016/j.jse.2026.06.005}
}
Kostenlos starten →